border=0
border=0
Enter any ticker symbol here to see the live quote & chart tools in action
Ticker:   
border=0 border=0 Benefits: /
  • Your filings are automatically published to your site as they are filed.
  • Investors don't have to leave your site to see filings.


  • Product Description
  • Once a report has been filed with the SEC it will be available on the website.



  • SEC Filings Section 16 Filings Only
     
    NOVADEL PHARMA INC filed this 8-K on 03/31/2010.
    Click on link to view section or document
    1. Entire Document including Exhibit(s)
    2. 8-K
    PAGE: 1 -
    PAGE: 2 -
    PAGE: 3 - SIGNATURES
    3. EX-1.1 - Underwriting agreement
    PAGE: 1 - Purchase Agreements
    PAGE: 2 - SEC
    PAGE: 3 - 1934 Act
    PAGE: 4 - Consents
    PAGE: 5 - Application of Takeover Protections; Rights Agreement
    PAGE: 6 - Insolvent
    PAGE: 7 - Foreign Corrupt Practices
    PAGE: 8 - Certificate of Incorporation
    PAGE: 9 - Contingent Obligation
    PAGE: 10 - Title
    PAGE: 11 - Internal Accounting and Disclosure Controls
    PAGE: 12 - Registration Eligibility
    PAGE: 13 - Management
    PAGE: 14 - No Additional Agreements
    PAGE: 15 - Indemnification
    PAGE: 16 -
    PAGE: 17 - Termination
    PAGE: 18 - Closing
    PAGE: 19 -
    PAGE: 20 - Placement Agent Information and Relationship
    PAGE: 21 - Signature page follows
    PAGE: 22 -
    4. EX-4.1 - Instruments defining the rights of security holders
    PAGE: 1 - Transfer Agent
    PAGE: 2 - Buy-In Price
    PAGE: 3 - Disputes
    PAGE: 4 - Required Reserve Amount
    PAGE: 5 - New Issuance Price
    PAGE: 6 -
    PAGE: 7 - Number of Warrant Shares
    PAGE: 8 - Variable Price Securities
    PAGE: 9 - Distribution
    PAGE: 10 - Corporate Event
    PAGE: 11 - Redemption Right Event
    PAGE: 12 - REISSUANCE OF WARRANTS
    PAGE: 13 - NOTICES
    PAGE: 14 - CONSTRUCTION; HEADINGS
    PAGE: 15 - TRANSFER
    PAGE: 16 - Black Scholes Consideration Value
    PAGE: 17 - Closing Bid Price
    PAGE: 18 - Convertible Securities
    PAGE: 19 - Options
    PAGE: 20 - signature page follows
    PAGE: 21 - IN WITNESS WHEREOF,
    PAGE: 22 - EXHIBIT A
    PAGE: 23 -
    PAGE: 24 - ACKNOWLEDGMENT
    5. EX-4.2 - Instruments defining the rights of security holders
    PAGE: 1 - Transfer Agent
    PAGE: 2 - Buy-In Price
    PAGE: 3 - Disputes
    PAGE: 4 - Required Reserve Amount
    PAGE: 5 - New Issuance Price
    PAGE: 6 -
    PAGE: 7 - Number of Warrant Shares
    PAGE: 8 - Variable Price Securities
    PAGE: 9 - Distribution
    PAGE: 10 - Corporate Event
    PAGE: 11 - Redemption Right Event
    PAGE: 12 - REISSUANCE OF WARRANTS
    PAGE: 13 - NOTICES
    PAGE: 14 - CONSTRUCTION; HEADINGS
    PAGE: 15 - TRANSFER
    PAGE: 16 - Black Scholes Consideration Value
    PAGE: 17 - Closing Bid Price
    PAGE: 18 - Convertible Securities
    PAGE: 19 - Options
    PAGE: 20 - signature page follows
    PAGE: 21 - IN WITNESS WHEREOF,
    PAGE: 22 - EXHIBIT A
    PAGE: 23 -
    PAGE: 24 - ACKNOWLEDGMENT
    6. EX-5.1 - Opinion regarding legality
    PAGE: 1 -
    7. EX-10.1 - Material contracts
    PAGE: 1 - 1. PURCHASE AND SALE OF COMMON SHARES AND WARRANTS.
    PAGE: 2 - Organization; Authority
    PAGE: 3 - Subsidiary.
    PAGE: 4 - 1934 Act
    PAGE: 5 - Principal Market
    PAGE: 6 - Dilutive Effect
    PAGE: 7 - Insolvent
    PAGE: 8 - Conduct of Business; Regulatory Permits
    PAGE: 9 - Equity Capitalization
    PAGE: 10 - Certificate of Incorporation
    PAGE: 11 - Absence of Litigation
    PAGE: 12 - Intellectual Property Rights
    PAGE: 13 - Internal Accounting and Disclosure Controls
    PAGE: 14 - Acknowledgement Regarding Buyers Trading Activity
    PAGE: 15 - BHCA
    PAGE: 16 - Money Laundering
    PAGE: 17 - No Additional Agreements
    PAGE: 18 - 10-K Filing
    PAGE: 19 - Reporting Period
    PAGE: 20 - Iroquois
    PAGE: 21 - Additional Issuance of Securities
    PAGE: 22 - Reservation of Shares
    PAGE: 23 -
    PAGE: 24 -
    PAGE: 25 - Dilutive Issuances
    PAGE: 26 - Corporate Existence
    PAGE: 27 - Exhibit C
    PAGE: 28 - Exhibit D
    PAGE: 29 - 8. TERMINATION.
    PAGE: 30 - Counterparts
    PAGE: 31 - Notices
    PAGE: 32 -
    PAGE: 33 - Successors and Assigns
    PAGE: 34 -
    PAGE: 35 -
    PAGE: 36 - U.S. Dollars
    PAGE: 37 - signature pages follow
    PAGE: 38 - IN WITNESS WHEREOF,
    PAGE: 39 - IN WITNESS WHEREOF,
    PAGE: 40 - IN WITNESS WHEREOF,
    PAGE: 41 - IN WITNESS WHEREOF,
    PAGE: 42 - IN WITNESS WHEREOF,
    PAGE: 43 - SCHEDULE OF BUYERS
    8. EX-10.2 - Material contracts
    PAGE: 1 - Termination of Agreement
    PAGE: 2 - Address for Notice:
    9. EX-99.1 - Exhibits not specifically designated by another number and by investment companies
    PAGE: 1 - FORWARD-LOOKING STATEMENTS:





    border=0
    Quote & Chart Package
    Basic Stock Chart
    Basic Stock Quote
    Embedded Quote / Chart
    Embedded Full Quote / Chart
    Interactive Chart
    Intraday Chart
    Pop Up Quote
    Scrolling Ticker

    You are viewing our Quote and Chart Demo using ticker symbol NVDL
    border=0

    T 800.650.1211     F 888.329.6696     E info@stockgroup.com   © 2004 Stockgroup Media Inc.    Disclaimer